FDA Approved: INTRAROSA — Original Application (Millicent US, Inc.)

View source ↗

Summary

FDA approved INTRAROSA (prasterone) from Millicent US, Inc. as an Original Application (NDA 208470) for the treatment of dyspareunia due to menopause. It is a v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia Due to Menopause
• Genitourinary Syndrome of Menopause
• Vaginal Atrophy

Drugs mentioned

• Intrarosa (prasterone)

Snippet

ORIG AP for INTRAROSA (PRASTERONE)